-
Schindler and colleagues in Munich evaluated whether visual exploration training alone or in combination with electromechanical vibration of the left neck muscles of patients while they engaged in visual search exercises were effective techniques for the rehabilitation of spatial neglect.
-
Diabetic painful sensory neuropathy remains difficult to treat. In this randomized, double-blind, placebo-controlled trial, sodium valproate was administered to 30 patients with efficacy and safety compared to 30 placebo-control patients.
-
The ISAT trial enrolled 2143 patients, primarily in Britain, with ruptured intracranial aneurysms and randomly assigned them to neurosurgical clipping or GDC coils. The results add another nail into the coffin of neurosurgical clipping.
-
Take a look at your paycheck; chances are if you are in the family planning field, it shows a slight increase from 2001.
-
This summer, the Bush administration officially announced it was cutting off all U.S. support for the United Nations Population Fund (UNFPA), the largest multilateral population assistance agency in the world.
-
As 2002 comes to a close, get ready to add a new lower-dose version of a popular oral contraceptive (OC) to your list of pills, and look to the upcoming 2003 introduction of a generic form of a long-time Pill favorite.
-
In discussing condom use, your college-age male patient tells you that he uses protection on a regular basis. But is he using condoms correctly?
-
When reviewing birth control options with a teen-age female patient, she tells you that she doesnt want to use the Pill because it will make her gain weight. What do you tell her?
-
Add just-published research to your counseling on Depo-Provera (depot medroxyprogesterone acetate or DMPA): Use of the injectable contraceptive is strongly associated with bone density loss; however bone loss appears to be largely reversible once the injections are stopped.1
-
If a large segment of your patient population is using the monthly contraceptive injection Lunelle, chances are that the last few weeks have been filled with contacting patients, answering questions, and counseling on backup contraception after the manufacturer issued a voluntary recall of prefilled syringes of the product.